Reality Check of U.S. Unilateral Demand for China to Close Consulate-General in Houston

Chen Zhuo
2020-07-29 17:41:52

On July 21, the U.S. made the unilateral provocation by making an outrageous demand that China close its Consulate-General in Houston. By so doing, the U.S. has grossly violated international law, the basic norms of international relations, and relevant provisions of the China-U.S. Consular Convention, and gravely damaged China-U.S. relations. China has made legitimate and necessary response.

The U.S. has been fabricating pretexts and spreading lies about its egregious decision. In a matter of just a few days, the U.S. has churned out different versions of the story. Lies, however, will always be lies even if they are repeated a thousand times. The different versions of the story concocted by the U.S. side have no factual base and mix black with white. In sum, the U.S. has failed to present even one single piece of solid evidence. It is important that we list U.S. false allegations vis-a-vis the facts. The purpose is to debunk the falsehoods and let people know the truths.

Please see the following text to find the truths.

1. False: China has stolen intellectual property from the US, including the COVID-19 vaccine research achievements. Closing the Chinese Consulate-General is “to protect American intellectual property and Americans’ private information”.

True: The US side is talking sheer nonsense. It has failed to back its allegation with even one single piece of solid evidence. The reality is, China is a big country in terms of innovation and intellectual property. It has become a main source driving intellectual property growth in the world. On COVID-19 vaccine research and development, China has been at the forefront and has no need to steal from the US .

◆ China is a big country in terms of innovation and intellectual property. It has kept strengthening the protection of scientific innovation and intellectual property rights. China is now among the world’s leading players in terms of scale and growth rate of innovation input. Its R&D expenditure had grown from RMB 300.31 billion yuan in 2006 to RMB 1.96779 trillion yuan in 2018, an average annual increase of 17% and rising from the sixth to the second in the world. China has the world’s biggest number of researchers. China’s IP offices have received the highest number of patent applications for nine years in a row. China also registered rapid increase in international patent applications and has risen to the world’s second biggest filer via WIPO’s Patent Cooperation Treaty (PCT) System. As pointed out in the WIPO annual report, China has become a main driving force for the overall growth in the global demand for intellectual property rights.

◆ China is one of the global leaders in the research and development of COVID-19 vaccines. At the moment, Chinese scientists are working on multiple vaccine projects along five technical routes. Vaccines with China’s independent intellectual property have entered clinical trials. The Beijing Institute of Biological Products under the China National Biotec Group, a subsidiary of the China National Pharmaceutical Group (Sinopharm), has set up the world’s largest production plant for COVID-19 vaccines. China’s National Medical Products Administration and other competent authorities are working to facilitate the deployment of vaccines. China is also working with relevant countries on vaccine research and development, production and distribution.

1 2 3 4 5

Related News